These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Significance of plasma B-type natriuretic peptide in hemodialysis patients: blood sample timing and comorbidity burden. Biasioli S; Zamperetti M; Borin D; Guidi G; De Fanti E; Schiavon R ASAIO J; 2007; 53(5):587-91. PubMed ID: 17885332 [TBL] [Abstract][Full Text] [Related]
49. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities. Ang DS; Kong CF; Kao MP; Struthers AD Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403 [TBL] [Abstract][Full Text] [Related]
51. Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension. Dimitriadis K; Tsioufis C; Selima M; Tsiachris D; Miliou A; Kasiakogias A; Andrikou E; Tousoulis D; Stefanadis C J Hum Hypertens; 2009 Oct; 23(10):668-73. PubMed ID: 19262583 [TBL] [Abstract][Full Text] [Related]
52. [B-type natriuretic peptides and subclinical target organ damage in essential hypertensive patients]. Peng XL; Lin ZP; Zhang RK; Zhang ZW Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2347-50. PubMed ID: 20965843 [TBL] [Abstract][Full Text] [Related]
53. The association of brain natriuretic peptide and insulin resistance in obesity-related hypertension. Tekes S; Cikim AS J Hum Hypertens; 2007 Jul; 21(7):546-50. PubMed ID: 17392814 [TBL] [Abstract][Full Text] [Related]
54. Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke. Jensen JK; Atar D; Kristensen SR; Mickley H; Januzzi JL Am J Cardiol; 2009 Jul; 104(2):287-91. PubMed ID: 19576362 [TBL] [Abstract][Full Text] [Related]
55. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure. Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067 [TBL] [Abstract][Full Text] [Related]
56. From treatment to organ damage; a 5-year follow-up study of ambulatory blood pressure in essential hypertension. Diversity between development of left ventricular hypertrophy and urinary albumin excretion. Stenehjem AE; Bjørnerheim R; Os I Blood Press; 2007; 16(2):87-94. PubMed ID: 17612906 [TBL] [Abstract][Full Text] [Related]
57. Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension. Fesler P; Safar ME; du Cailar G; Ribstein J; Mimran A J Hypertens; 2007 Sep; 25(9):1915-20. PubMed ID: 17762657 [TBL] [Abstract][Full Text] [Related]
58. Paradoxical changes in brain natriuretic peptide levels and loading conditions after intravenous conscious sedation. Vinch CS; Hill JC; Logsetty G; Tighe DA; Meyer TE; Aurigemma GP J Am Soc Echocardiogr; 2004 Nov; 17(11):1191-6. PubMed ID: 15502796 [TBL] [Abstract][Full Text] [Related]
59. Home blood pressure measurement may lead to less strict control of office blood pressure. Eto K; Tsuchihashi T; Ohta Y; Onaka U; Ueno M Clin Exp Hypertens; 2008 Apr; 30(3):225-31. PubMed ID: 18425702 [TBL] [Abstract][Full Text] [Related]
60. Antihypertensive efficacy of the losartan/hydrochlorothiazide combination and its effect on plasma B-type natriuretic peptide in hypertensive patients uncontrolled by angiotensin II type 1 receptor antagonist-based therapy: a multicentre prospective observational study. Meno H; Inou T; Tanaka M; Tsuchiya Y; Shiga Y; Kobayashi K; Nakamura Y; Ota T; Kubara I Clin Drug Investig; 2012 Mar; 32(3):171-8. PubMed ID: 22188593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]